Researchers

HAYASHI Hidetoshi

Faculty	Department of Medicine / Graduate School of Medical Sciences
Researchmap	https://researchmap.jp/hayashi_h

Apr. 2023 - Today , Kindai University, Faculty of Medicine Department of Medical Oncology Professor
Apr. 2022 - Today , Kindai University, Faculty of Medicine Department of Medical Oncology 特命准教授
Apr. 2020 - Mar. 2022 , 近畿大学医学部内科学腫瘍内科講師
Oct. 2015 - Mar. 2020 , Kindai university hospital Department of Medical Oncology Lecturer
Apr. 2015 - Sep. 2015 , Kindai university hospital Department of Medical Oncology Assistant professor
Apr. 2013 - Mar. 2015 , Kishiwada City Hospital Department of Medical Oncology Director
Apr. 2009 - Mar. 2013 , Kindai university hospital Department of Medical Oncology assistant professor
Apr. 2006 - Mar. 2009 , Kurashiki Central Hospital Respiratory Medicine Medical Staff
Apr. 2003 - Mar. 2006 , Sumitomo Hospital General Medicine Resident

Cancer of Unknown Primary, Lung Cancer, Gene analysis, medical oncology, immune checkpoint inhibitor

Clinical Characteristics and Outcomes of SMARCA4-Mutated or Deficient Malignancies: A Systematic Review of Case Reports and Series
Ryuichi Ohta; Natsumi Yamamoto; Kaoru Tanaka; Chiaki Sano; Hidetoshi Hayashi
Cancers 16, Aug. 2025
Current treatment landscape for patients with non–small cell lung cancer with common EGFR mutations
Masayuki Miyata; Hidetoshi Hayashi
Respiratory Investigation Jul. 2025
Patritumab Deruxtecan (HER3-DXd; MK-1022) in Non–Small Cell Lung Cancer After Platinum-Based Chemotherapy and Immunotherapy
Conor E. Steuer; Hidetoshi Hayashi; Wu-Chou Su; Makoto Nishio; Melissa L. Johnson; Dong-Wan Kim; Erminia Massarelli; Enriqueta Felip; Kathryn A. Gold; Haruyasu Murakami; Christina S. Baik; Sang-We Kim; Egbert F. Smit; Masahiro Fujimura; Pang-Dian Fan; Karine Truchon; Xin Su; David W. Sternberg; Pasi A. Jänne
Journal of Clinical Oncology 24, Jun. 2025

Prognostic impact of EMT-related genes on post-operative prognosis in hepatocellular carcinoma. , 永井知行; 荒尾徳三; 松本和子; 藤田至彦; 林秀敏; 木村英晴; 萩原智; 櫻井俊治; 上嶋一臣; 土師誠二; 工藤正俊; 西尾和人 , AACR 103rd Annual Meeting 2011 , Mar. 2012
進行肺腺癌を対象としたゲフィチニブ／S-1併用療法第１層臨床試験 , 清田秀美; 岡本勇; 田中薫; 林秀敏; 寺嶋応顕; 東公一; 武田真幸; 米阪仁雄; 藤阪保仁; 鶴谷純司; 宮﨑昌樹; 佐藤太郎; 倉田宝保; 中川和彦 , 第51回日本肺癌学会総会 , Nov. 2010
進行肺腺癌を対象としたゲフェチニブ／S-1 併用療法第１相臨床試験 , 清田秀美; 岡本勇; 谷﨑潤子; 文田壮一; 岡本邦男; 牧村ちひろ; 竹澤健; 田中薫; 林秀敏; 岡本渉; 寺嶋応顕; 東公一; 金田裕靖; 武田真幸; 上田眞也; 米阪仁雄; 藤阪保仁; 鶴谷純司; 宮﨑昌樹; 佐藤太郎; 倉田宝保; 中川和彦 , 第92回日本肺癌学会関西支部会 , Jul. 2010

Drug Therapy Based on Cancer Genome Profiling (CGP, Comprehensive Genomic Profiling) in Lung Cancer , 川中雄介; 米阪仁雄; 米阪仁雄; 稲垣千昌; 稲垣千昌; 高濱隆幸; 高濱隆幸; 白石直樹; 坂井和子; 西尾和人; 中川和彦; 林秀敏 , 日本がん分子標的治療学会学術集会プログラム・抄録集 , 28th , 2024
Classification of tissue origin of cancer by methylation profiling , 坂井和子; デベラスコマルコ; 三谷誠一郎; 倉由吏恵; 源周治; 波江野高大; 林秀敏; 林秀敏; 西尾和人; 西尾和人 , 日本癌学会学術総会抄録集(Web) , 83rd , 2024
Current Status and Issues of “imNET“ Activities of the Immune-Related Adverse Events Management Team in Kindai Hospital , 高濱隆幸; 磯本晃佑; 鈴木慎一郎; 渡邉諭美; 金村宙昌; 稲垣千晶; 三谷誠一郎; 谷崎潤子; 吉田健史; 田中薫; 川上尚人; 岩朝勤; 米阪仁雄; 藤原季美子; 萩原智; 西山理; 桑原基; 竹久志穂; 高橋直美; 林秀敏 , 日本臨床腫瘍学会学術集会(CD-ROM) , 21st , 2024

免疫チェックポイント阻害剤の奏効性の判定を補助する方法、試薬キット、装置及びコンピュータプログラム , 本庶佑, 茶本健司, 林秀敏, 中川和彦, 後藤恵, 宇賀均
免疫チェックポイント阻害剤の奏効性の判定を補助する方法、試薬キット、装置及びコンピュータプログラム , 本庶佑, 茶本健司, 林秀敏, 中川和彦, 後藤恵, 宇賀均 , 特許第7251738号

Japan Society for the Promotion of Science, Grants-in-Aid for Scientific Research, Validation study of a model for estimating the primary organ of cancer of unknown primary by methylation analysis of circulating tumor DNA , Kindai University
Japan Society for the Promotion of Science, Grants-in-Aid for Scientific Research, Validation study of a model to estimate the primary organ of cancer of unknown primary , Kindai University
Japan Society for the Promotion of Science, Grants-in-Aid for Scientific Research, Analysis of the risk factors for the development and severity of immune-related adverse events by immune checkpoint inhibitors , Kindai University